ID   NP1L4_HUMAN             Reviewed;         375 AA.
AC   Q99733; B2R6J4; F5HFY4;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   28-JAN-2026, entry version 200.
DE   RecName: Full=Nucleosome assembly protein 1-like 4;
DE   AltName: Full=Histone chaperone NAP1L4 {ECO:0000305};
DE   AltName: Full=Nucleosome assembly protein 2 {ECO:0000303|PubMed:8923002};
DE            Short=NAP-2 {ECO:0000303|PubMed:8923002};
GN   Name=NAP1L4 {ECO:0000312|HGNC:HGNC:7640};
GN   Synonyms=NAP2 {ECO:0000303|PubMed:8923002};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=8923002; DOI=10.1093/hmg/5.11.1743;
RA   Hu R.-J., Lee M.P., Johnson L.A., Feinberg A.P.;
RT   "A novel human homologue of yeast nucleosome assembly protein, 65 kb
RT   centromeric to the p57KIP2 gene, is biallelically expressed in fetal and
RT   adult tissues.";
RL   Hum. Mol. Genet. 5:1743-1748(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Okuwaki M., Kato K., Nagata K.;
RT   "human nucleosome assembly protein 1-like 4b.";
RL   Submitted (MAY-2009) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=9325046; DOI=10.1006/geno.1997.4868;
RA   Rodriguez P., Munroe D., Prawitt D., Chu L.L., Bric E., Kim J., Reid L.H.,
RA   Davies C., Nakagama H., Loebbert R., Winterpacht A., Petruzzi M.J.,
RA   Higgins M.J., Nowak N., Evans G., Shows T., Weissman B.E., Zabel B.,
RA   Housman D.E., Pelletier J.;
RT   "Functional characterization of human nucleosome assembly protein-2
RT   (NAP1L4) suggests a role as a histone chaperone.";
RL   Genomics 44:253-265(1997).
RN   [7]
RP   SUBCELLULAR LOCATION, AND PHOSPHORYLATION.
RX   PubMed=10764593; DOI=10.1006/jmbi.2000.3674;
RA   Rodriguez P., Pelletier J., Price G.B., Zannis-Hadjopoulos M.;
RT   "NAP-2: histone chaperone function and phosphorylation state through the
RT   cell cycle.";
RL   J. Mol. Biol. 298:225-238(2000).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells
RT   and high confident phosphopeptide identification by cross-validation of
RT   MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-51 AND SER-125, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by enrichment
RT   and fractionation of phosphopeptides with strong anion exchange
RT   chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125 AND SER-304, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-5; SER-7; SER-12; THR-51; SER-54 AND SER-125, CLEAVAGE OF
RP   INITIATOR METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-5; SER-7; SER-12 AND SER-125, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-5; SER-7; SER-12; THR-51;
RP   THR-58 AND SER-125, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [20]
RP   INTERACTION WITH CHIKUNGUNYA VIRUS NON-STRUCTURAL PROTEIN 3 (MICROBIAL
RP   INFECTION).
RX   PubMed=29899097; DOI=10.1128/jvi.00838-18;
RA   Meshram C.D., Agback P., Shiliaev N., Urakova N., Mobley J.A., Agback T.,
RA   Frolova E.I., Frolov I.;
RT   "Multiple Host Factors Interact with the Hypervariable Domain of
RT   Chikungunya Virus nsP3 and Determine Viral Replication in Cell-Specific
RT   Mode.";
RL   J. Virol. 92:0-0(2018).
CC   -!- FUNCTION: Acts as a histone chaperone in nucleosome assembly.
CC       {ECO:0000269|PubMed:9325046}.
CC   -!- SUBUNIT: Interacts with core (H2A, CD2APH2B, H3, H4) and linker (H1)
CC       histones. {ECO:0000269|PubMed:9325046}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Chikungunya virus non-
CC       structural protein 3 (via C-terminus). {ECO:0000269|PubMed:29899097}.
CC   -!- INTERACTION:
CC       Q99733; P55209: NAP1L1; NbExp=4; IntAct=EBI-2255116, EBI-356392;
CC       Q99733; P04608: tat; Xeno; NbExp=3; IntAct=EBI-2255116, EBI-6164389;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10764593,
CC       ECO:0000269|PubMed:9325046}. Chromosome {ECO:0000250|UniProtKB:Q78ZA7}.
CC       Cytoplasm {ECO:0000269|PubMed:10764593, ECO:0000269|PubMed:9325046}.
CC       Note=Present in the cytoplasm and excluded from the nucleus during
CC       G0/G1 phase, then relocates to the nucleus by the time cells are in S
CC       phase (PubMed:9325046). Phosphorylated form localizes in the cytoplasm
CC       during the G0/G1 transition, whereas dephosphorylation leads to
CC       relocalization into the nucleus at the G1/S-boundary (PubMed:10764593).
CC       {ECO:0000269|PubMed:10764593, ECO:0000269|PubMed:9325046}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q99733-1; Sequence=Displayed;
CC       Name=2; Synonyms=NAP1L4b {ECO:0000303|Ref.2};
CC         IsoId=Q99733-2; Sequence=VSP_053910;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Biallelically expressed in fetal and
CC       adult tissues. Highest levels in testis. {ECO:0000269|PubMed:8923002}.
CC   -!- PTM: Phosphorylated at the G0/G1 boundary but it is not phosphorylated
CC       in S-phase. Phosphorylated protein remains in the cytoplasm in a
CC       complex with histones during the G0/G1 transition, whereas
CC       dephosphorylation triggers its transport into the nucleus at the G1/S-
CC       boundary. {ECO:0000269|PubMed:10764593}.
CC   -!- PTM: Polyglutamylated by TTLL4, a modification that occurs exclusively
CC       on glutamate residues and results in polyglutamate chains on the gamma-
CC       carboxyl group. Some residues may also be monoglycylated but not
CC       polyglycylated due to the absence of functional TTLL10 in human (By
CC       similarity). {ECO:0000250|UniProtKB:Q78ZA7, ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the nucleosome assembly protein (NAP) family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U77456; AAC50870.1; -; mRNA.
DR   EMBL; AB500094; BAH95827.1; -; mRNA.
DR   EMBL; AK312599; BAG35491.1; -; mRNA.
DR   EMBL; AC131971; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC022090; AAH22090.1; -; mRNA.
DR   CCDS; CCDS41599.1; -. [Q99733-1]
DR   CCDS; CCDS91410.1; -. [Q99733-2]
DR   RefSeq; NP_001356304.1; NM_001369375.1. [Q99733-1]
DR   RefSeq; NP_001356305.1; NM_001369376.1. [Q99733-1]
DR   RefSeq; NP_001356306.1; NM_001369377.1. [Q99733-1]
DR   RefSeq; NP_001356307.1; NM_001369378.1. [Q99733-1]
DR   RefSeq; NP_001356308.1; NM_001369379.1. [Q99733-1]
DR   RefSeq; NP_001356309.1; NM_001369380.1. [Q99733-2]
DR   RefSeq; NP_001356310.1; NM_001369381.1. [Q99733-2]
DR   RefSeq; NP_001356311.1; NM_001369382.1. [Q99733-2]
DR   RefSeq; NP_001356312.1; NM_001369383.1. [Q99733-2]
DR   RefSeq; NP_001356313.1; NM_001369384.1. [Q99733-2]
DR   RefSeq; NP_001356314.1; NM_001369385.1. [Q99733-2]
DR   RefSeq; NP_001356315.1; NM_001369386.1. [Q99733-2]
DR   RefSeq; NP_001356317.1; NM_001369388.1. [Q99733-2]
DR   RefSeq; NP_005960.1; NM_005969.4. [Q99733-1]
DR   AlphaFoldDB; Q99733; -.
DR   SMR; Q99733; -.
DR   BioGRID; 110757; 233.
DR   FunCoup; Q99733; 3211.
DR   IntAct; Q99733; 95.
DR   MINT; Q99733; -.
DR   STRING; 9606.ENSP00000369915; -.
DR   ChEMBL; CHEMBL3886061; -.
DR   GlyGen; Q99733; 2 sites, 1 O-linked glycan (1 site).
DR   iPTMnet; Q99733; -.
DR   MetOSite; Q99733; -.
DR   PhosphoSitePlus; Q99733; -.
DR   SwissPalm; Q99733; -.
DR   BioMuta; NAP1L4; -.
DR   DMDM; 2498672; -.
DR   jPOST; Q99733; -.
DR   MassIVE; Q99733; -.
DR   PaxDb; 9606-ENSP00000369915; -.
DR   PeptideAtlas; Q99733; -.
DR   ProteomicsDB; 27835; -.
DR   ProteomicsDB; 78450; -. [Q99733-1]
DR   Pumba; Q99733; -.
DR   Antibodypedia; 23223; 73 antibodies from 21 providers.
DR   DNASU; 4676; -.
DR   Ensembl; ENST00000380542.9; ENSP00000369915.4; ENSG00000205531.15. [Q99733-1]
DR   Ensembl; ENST00000526115.5; ENSP00000436397.1; ENSG00000205531.15. [Q99733-2]
DR   Ensembl; ENST00000616696.1; ENSP00000478654.1; ENSG00000273562.4. [Q99733-2]
DR   Ensembl; ENST00000619695.4; ENSP00000483728.1; ENSG00000273562.4. [Q99733-1]
DR   Ensembl; ENST00000620138.4; ENSP00000481412.1; ENSG00000205531.15. [Q99733-2]
DR   Ensembl; ENST00000632791.1; ENSP00000487984.1; ENSG00000273562.4. [Q99733-2]
DR   GeneID; 4676; -.
DR   KEGG; hsa:4676; -.
DR   MANE-Select; ENST00000380542.9; ENSP00000369915.4; NM_005969.4; NP_005960.1.
DR   UCSC; uc001lxc.4; human. [Q99733-1]
DR   AGR; HGNC:7640; -.
DR   ClinPGx; PA31442; -.
DR   CTD; 4676; -.
DR   DisGeNET; 4676; -.
DR   GeneCards; NAP1L4; -.
DR   HGNC; HGNC:7640; NAP1L4.
DR   HPA; ENSG00000205531; Low tissue specificity.
DR   MIM; 601651; gene.
DR   OpenTargets; ENSG00000205531; -.
DR   VEuPathDB; HostDB:ENSG00000205531; -.
DR   eggNOG; KOG1507; Eukaryota.
DR   GeneTree; ENSGT00940000153362; -.
DR   HOGENOM; CLU_038841_3_0_1; -.
DR   InParanoid; Q99733; -.
DR   OMA; YSGDFMY; -.
DR   OrthoDB; 27325at2759; -.
DR   PAN-GO; Q99733; 5 GO annotations based on evolutionary models.
DR   PhylomeDB; Q99733; -.
DR   PathwayCommons; Q99733; -.
DR   SignaLink; Q99733; -.
DR   Agora; ENSG00000205531; -.
DR   BioGRID-ORCS; 4676; 9 hits in 1160 CRISPR screens.
DR   CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities.
DR   ChiTaRS; NAP1L4; human.
DR   GeneWiki; NAP1L4; -.
DR   GenomeRNAi; 4676; -.
DR   Pharos; Q99733; Tbio.
DR   PRO; PR:Q99733; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q99733; protein.
DR   Bgee; ENSG00000205531; Expressed in ventricular zone and 100 other cell types or tissues.
DR   ExpressionAtlas; Q99733; baseline and differential.
DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IBA:GO_Central.
DR   GO; GO:0042393; F:histone binding; IBA:GO_Central.
DR   GO; GO:0031491; F:nucleosome binding; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0051082; F:unfolded protein binding; TAS:ProtInc.
DR   GO; GO:0006334; P:nucleosome assembly; IDA:UniProtKB.
DR   FunFam; 1.20.5.1500:FF:000001; Nucleosome assembly protein 1-like 1; 1.
DR   FunFam; 3.30.1120.90:FF:000001; Nucleosome assembly protein 1-like 1; 1.
DR   Gene3D; 1.20.5.1500; -; 1.
DR   Gene3D; 3.30.1120.90; Nucleosome assembly protein; 1.
DR   InterPro; IPR037231; NAP-like_sf.
DR   InterPro; IPR002164; NAP_family.
DR   PANTHER; PTHR11875; TESTIS-SPECIFIC Y-ENCODED PROTEIN; 1.
DR   Pfam; PF00956; NAP; 1.
DR   SUPFAM; SSF143113; NAP-like; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Chaperone; Chromosome; Cytoplasm;
KW   Nucleus; Phosphoprotein; Proteomics identification; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:22223895"
FT   CHAIN           2..375
FT                   /note="Nucleosome assembly protein 1-like 4"
FT                   /id="PRO_0000185658"
FT   REGION          1..31
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          116..137
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          339..375
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           265..271
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        20..31
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        121..137
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:22223895"
FT   MOD_RES         5
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   MOD_RES         7
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   MOD_RES         12
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   MOD_RES         51
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163"
FT   MOD_RES         53
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q78ZA7"
FT   MOD_RES         54
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         58
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         105
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P28656"
FT   MOD_RES         125
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:18318008, ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   MOD_RES         146
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q78ZA7"
FT   MOD_RES         304
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   VAR_SEQ         375
FT                   /note="V -> KEPSQPAECKQQ (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_053910"
FT   CONFLICT        107
FT                   /note="R -> K (in Ref. 3; BAG35491)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   375 AA;  42823 MW;  788E1F9F5BC8FD45 CRC64;
     MADHSFSDGV PSDSVEAAKN ASNTEKLTDQ VMQNPRVLAA LQERLDNVPH TPSSYIETLP
     KAVKRRINAL KQLQVRCAHI EAKFYEEVHD LERKYAALYQ PLFDKRREFI TGDVEPTDAE
     SEWHSENEEE EKLAGDMKSK VVVTEKAAAT AEEPDPKGIP EFWFTIFRNV DMLSELVQEY
     DEPILKHLQD IKVKFSDPGQ PMSFVLEFHF EPNDYFTNSV LTKTYKMKSE PDKADPFSFE
     GPEIVDCDGC TIDWKKGKNV TVKTIKKKQK HKGRGTVRTI TKQVPNESFF NFFNPLKASG
     DGESLDEDSE FTLASDFEIG HFFRERIVPR AVLYFTGEAI EDDDNFEEGE EGEEEELEGD
     EEGEDEDDAE INPKV
//
